PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹91 Cr | ₹18 Cr | ₹-186 Cr | ₹376 Cr | ₹835 Cr |
What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹91 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹-186 Cr |
| Mar2022 | ₹376 Cr |
| Mar2021 | ₹835 Cr |
How is Consolidated Net Profit of PIRAMAL PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹91 Cr | 411.39 | |
| Mar2024 | ₹18 Cr | Positive | |
| Mar2023 | ₹-186 Cr | Negative | |
| Mar2022 | ₹376 Cr | -54.98 | |
| Mar2021 | ₹835 Cr | - | |
Compare Consolidated Net Profit of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,199.4 Cr | -2.4% | 1% | -17.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,933.0 Cr | -0.7% | -3.6% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,833.0 Cr | 1.1% | -1.2% | -0.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,549.0 Cr | 1.6% | 1.4% | 36.7% | Stock Analytics | |
| CIPLA | ₹113,155.0 Cr | 0.7% | 2.6% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,654.0 Cr | -0.9% | -2.5% | 1.2% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -2.4% |
1% |
-17.8% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
You may also like the below Video Courses